Dr. Sara Nageeb El-Helaly graduated from Faculty of Pharmacy, Cairo university in 2003. She acquired her PhD in brain targeting intranasal liposomal systems from Cairo University in 2015. After which she acquired a Professional Certified Trainer (PCT) Certificate from the American University in Cairo (AUC) beside holding a full-time position as a lecturer in Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo university, and lecturing as a part-timer in various academic institutions.

In 2020, she settled as a full-time associate professor and head of pharmaceutics and industrial pharmacy department in NGU, School of Pharmacy. In parallel with the academia, she is the chairman of the Institutional Review Board at Pharma Solutions, a Contract Research Organization, since 2016. In 2022, she has been appointed a member of the specialized scientific committees for the evaluation of the quality file of pharmaceutical products submitted under the CTD registration system, variation committee of the Egyptian Drug Authority (EDA) and a member of the expert committee in the Egyptian Pharmacopoeia. In 2023, she joined the United States Pharmacopoeia convention (USP) as a consultant and strategic customer development. In 2024, she was appointed as public policy and regulatory affairs senior manager for the EMEA region. She co-authored a number of publications in the field of formulation development, nanotechnology, and green chemistry.